89bio
Direct message the job poster from 89bio
Executive Director @ 89bio | Clinical Development, PharmD
89bio is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for treating liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is engineered to treat nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Recent clinical data indicate BIO89-100's favorable safety profile and significant reductions in liver fat and lipid markers. Headquartered in San Francisco with operations in Herzliya, Israel, 89bio values putting patients first, operating with integrity, collaborating as a team, and maintaining a scientific and rational approach.
This is a full-time hybrid role for a Director, Clinical Development. The role is based in San Francisco, CA, with flexibility for some work-from-home arrangements. The Director, Clinical Development will be responsible for clinical trial site engagement for a large Phase 3 program in MASH and will have a primary role in developing relationships with gastroenterologists/hepatologists. Other clinical research responsibility will involve working with a multidisciplinary team to review study data. The position will involve 50% travel.